Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
09/1995
09/20/1995EP0672669A1 Process for the preparation of clavulanic acid
09/20/1995EP0672038A1 Herbicides
09/19/1995US5451586 Substance P antagonist
09/13/1995EP0670839A1 Process for the preparation of 9-amino camptothecin
09/13/1995EP0670835A1 Process for preparing benzopyran compounds
09/13/1995EP0449940B1 New therapeutically active compound and a process for its preparation
09/06/1995EP0669924A1 Regioselective synthesis of 4-chloro-2-thiophenecarboxylic acid.
09/06/1995EP0669919A1 Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists
09/06/1995EP0669912A1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists
09/06/1995CN1107885A Removing and recovering plant polyphenols
09/06/1995CN1107835A A process for preparing pharmaceutical composition showing properties in against human immunodeficiency virus
09/05/1995US5447929 Collagenase inhibitors for degenerative joint disease, antitumor agents or atherosclerosis
08/1995
08/30/1995EP0668860A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
08/30/1995EP0668762A1 Butenyl-substituted taxanes and composition
08/29/1995US5446159 Process for preparing imidazopyridine derivatives
08/24/1995WO1995022536A1 6-substituted mycophenolic and derivatives with immunosuppressive activity
08/24/1995CA2183533A1 6-substituted mycophenolic acid and derivatives
08/23/1995EP0668271A1 Process for the preparation of isocyanurate-group containing polyisocyanates
08/23/1995CN1107153A Process
08/22/1995US5444072 Useful in treatment of autoimmune disorders, psoriasis, inflammatory diseases, rheumatoid arthritis
08/22/1995US5444062 Quinazolines derivatives for enhancing antitumor activity
08/17/1995WO1995021821A1 New compounds with analgesic and local anaesthetic effect
08/17/1995CA2181068A1 New compounds with analgesic and local anaesthetic effect
08/16/1995CN1106812A Tricyclic diazepine vasopressin antagonists
08/16/1995CN1106803A Fungicidal optically active 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives
08/15/1995US5442055 Azetidinone compound and process for preparation thereof
08/09/1995CN1106251A Shampoo-conditioner composition
08/08/1995US5439922 Piperidyl-substituted indoles for treating anxiety
08/08/1995US5439917 Active compounds
08/03/1995WO1995020584A1 Method of synthesizing gamma pyrones
08/03/1995WO1995020582A1 Δ12,13-iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them
08/03/1995CA2181463A1 Method of synthesizing gamma pyrones
08/03/1995CA2179176A1 .delta.12,13-iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them
08/02/1995EP0544765B1 Piperazinyl derivatives with affinity for 5-HT receptors
08/02/1995CN1106009A Preparation of imidazopyridine derivative
08/02/1995CN1106007A Novel sulfonylamino pyrimidines
08/02/1995CN1105996A Preparation of imidazopyridine derivative
08/01/1995US5438074 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
08/01/1995US5438052 Cephalosporin derivatives
07/1995
07/25/1995US5436266 Compounds
07/19/1995CN1105360A 1-|2H-1-benzopyran-2-one-8yl¨-piperazin derivative
07/19/1995CN1105358A N-substituted azabicycloheptane derivatives, the preparation and use thereof
07/18/1995US5434168 4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol
07/11/1995US5432282 Process for preparing 1,4-dihydro-2-amino-3-carboxy-5-cyano-pyridine derivatives
07/11/1995US5432164 C2,N6 -disubstituted adenosine derivatives
07/06/1995WO1995018123A1 Pyridine derivatives as pesticides
07/06/1995CA2179293A1 Pyridine derivatives as pesticides
07/05/1995EP0556310B1 Quinazolines derivatives for enhancing antitumor activity
06/1995
06/28/1995EP0659184A1 Optically active hydroquinine (amino-3 phenyl)-1 ethanesulfonate, preparation and use thereof.
06/27/1995US5428032 Heterocyclic compounds
06/21/1995EP0658545A1 Decahydro-isoquinoline derivatives
06/21/1995CN1028990C Hiv-inhibiting benzeneacetamide derivatives
06/15/1995WO1995015962A1 Substituted benzimidazole, processes for its preparation and its pharmaceutical use
06/14/1995EP0657443A1 Optically active carboxamide derivative
06/13/1995US5424428 (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]pr
05/1995
05/31/1995EP0573467B1 NEUROLEPTIC PERHYDRO-1H-PYRIDO 1,2-a]PYRAZINES
05/30/1995USRE34960 Carbapenem compounds, and compositions containing them
05/30/1995US5420310 Conversion of 15-beta to 15-alpha 5,6,7-trinor-4,8-inter-m-phenylene PGI2 derivatives
05/30/1995US5420277 Intermediates for the preparation of heteroaryl derivatives of monocyclic beta-lactam antiobiotics
05/30/1995CA1335733C 1h-indazole-3-acetic acids as aldose reductase inhibitors
05/24/1995EP0654031A1 Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
05/17/1995EP0652872A1 Optically pure salts of pyridinylmethyl sulfinyl-1h-benzimidazole compounds
05/17/1995CN1028429C Method for preparing of substd. Thieno (2,3-B)(1,5) benzodiazepine derivatives
05/16/1995US5416080 Cephalosporins
05/16/1995CA1335590C Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
05/03/1995EP0650964A1 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives
05/03/1995EP0626953A4 Novel sidechain-bearing taxanes and intermediates thereof.
05/03/1995CA2134630A1 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives
05/02/1995US5412107 Phenylsulfonylchloride intermediates useful for the preparation of herbicidally active sulfonylureas
04/1995
04/26/1995EP0649424A1 Dioxcyclobutene derivatives as angiotensin ii antagonists
04/26/1995EP0649407A1 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
04/26/1995EP0572437B1 2,4-diaminoquinazolines derivatives for enhancing antitumor activity
04/26/1995EP0537300B1 Oxazolidinedione hypoglycemic and hypocholesterolemic agents
04/25/1995US5409931 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
04/20/1995CA2172960A1 Treatment of allergic disorders with terfenadine carboxylate
04/19/1995EP0550635B1 Fused ring analogs of nitrogen containing nonaromatic heterocycles
04/19/1995EP0510036B1 2-substituted 4,5-diphenyl-imidazoles
04/19/1995CN1028231C Therapeutically active compound and process for preparation
04/18/1995US5407954 Arylalkoxyphenoxy-imidazoline compounds
04/18/1995CA1335286C Labile ketone derivatives of 3-substituted-1-alkylamino 2-propanols and their use as .beta.-adrenergic blockers
04/12/1995EP0647231A1 N-substituted 3-azabicyclo 3.2.0]heptane derivates useful as neuroleptic agents, etc.
04/12/1995CN1028143C Fungicidal oxazolidinones
04/11/1995US5405857 3-substituted 1,2,3,4,-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds
04/11/1995US5405854 Sulfonamidocarboxamides
04/11/1995US5405829 Substituted pyrazolypyrazoles and their use as herbicides
04/06/1995WO1995009169A1 Process for the preparation of 9-amino camptothecin
04/06/1995CA2133612A1 Process for the preparation of acid chloride compounds
04/05/1995EP0646566A1 Process for the preparation of acid chloride compounds
04/05/1995EP0646116A1 Process and intermediates for bis-aza-bicyclic anxiolytic agents
04/05/1995EP0646115A1 Heterocyclic-cyclic amine derivatives
04/04/1995US5403852 Oxazole derivatives, their preparation and pharmaceutical compositions containing them
03/1995
03/30/1995WO1995008549A1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins
03/30/1995WO1995008536A1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists
03/30/1995CA2172529A1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins
03/29/1995EP0645388A1 Process for the production of imidazopyridines
03/22/1995EP0643700A1 New substituted pyrazolylpyrazoles, processes for their preparation, as well as intermediates, and their use as herbicides.
03/22/1995CN1100421A Process for preparation of a pharmaceutical composition containing a triazole derivative
03/21/1995US5399720 Production of oxetanones
03/21/1995US5399574 5-hydroxytryptamine agonists; vasoconstrictors
03/18/1995CA2131134A1 Process for preparing imidazopyridine derivatives
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 105